Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01810302 · ClinicalTrials.gov registry record · Phase 2
Safety Study of Nicardipine to Treat Cerebral Vasospasm
A Phase 2 study, sponsored by University of Florida.
- Terminated
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT01810302 is a Phase 2 study that was terminated before completion, run by University of Florida. The registered enrollment target is 2 participants.
The verdict
NCT01810302, a Phase 2 study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if intrathecal nicardipine is safe for the treatment of cerebral vasospasm.
Interventions
- DRUG Nicardipine hydrochloride
- DRUG Preservative-free normal saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01810302
The ClinicalTrials.gov registry entry for NCT01810302 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nicardipine hydrochloride is the first listed.
NCT01810302 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01810302 about?
NCT01810302 is a clinical study titled "Safety Study of Nicardipine to Treat Cerebral Vasospasm". The purpose of this study is to determine if intrathecal nicardipine is safe for the treatment of cerebral vasospasm.
What is the current status of trial NCT01810302?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2013-08. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01810302?
The interventions under investigation include: Nicardipine hydrochloride (DRUG), Preservative-free normal saline (DRUG).
Who is sponsoring clinical trial NCT01810302?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.